Liquid Biopsy: A Leading Driver Behind Government Funding Boosts Liquid Biopsy Market Market Expansion in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Liquid Biopsy Industry Market Size Be by 2025?
The market size of liquid biopsy has seen a swift expansion recently. It is projected to rise from $1.25 billion in 2024 to $1.46 billion in 2025, showcasing a compound annual growth rate (CAGR) of 16.4%. The previous growth period witnessed was the result of advancements in cancer studies, non-invasiveness, tailored medical treatment, regulatory sanctions, and early cancer detection.

What's the Long-Term Growth Forecast for the Liquid Biopsy Market Size Through 2029?
In the upcoming years, the liquid biopsy market is anticipated to witness significant expansion, skyrocketing to a size of $2.76 billion by 2029, with a compound annual growth rate (CAGR) of 17.2%. Factors contributing to this predicted growth during the forecast period include proliferating applications, surveillance of cancer, breakthrough technologies, companion diagnostics and biomarker identification. Key trends during this period are expected to be cancer detection and surveillance, therapeutic monitoring, monitoring of minimal residual disease (MRD), and the usage of liquid biopsy in non-cancerous applications.

View the full report here:
https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

What Are the Key Growth Drivers Fueling the Liquid Biopsy Market Expansion?
The progression of the liquid biopsy market is propelled by government funding intended to enhance cancer detection methods. This funding assists investigators in the realms of drug discovery, diagnosis, and disease treatment, such as cancer. For instance, in 2022, the National Institute of Health (NIH), a medical research institution based in the US, received funding of $46.6 billion, with $6.9 billion designated to the National Cancer Institute (NCI), an agency conducting cancer research in America. Consequently, these governmental contributions foster the positive expansion of the liquid biopsy market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2815&type=smp

What Are the Key Trends Driving Liquid Biopsy Market Growth?
Firms are rapidly embracing new market dynamics and prioritizing advanced product introductions to satisfy the growing demand for liquid biopsy products and services, boost their revenue, and achieve a competitive advantage. In June 2023, the US healthcare firm Laboratory Corporation of America Holdings, for instance, rolled out a liquid biopsy test, Labcorp Plasma Focus. This test has been created to detect cancer-related biomarkers in people with advanced or metastatic solid tumors. The study involves examining the cell-free DNA (cfDNA) found in a patient's blood sample to build a genomic profile of their tumor, enabling oncologists to refine their healthcare management approach with personalized, highly targeted therapy plans. This shows that investment in advanced product development in the liquid biopsy market is a high priority for many companies.

How Is the Liquid Biopsy Market Segmented?
The liquid biopsy market covered in this report is segmented -

1) By Product: Assays Kits, Instruments, Services
2) By Clinical Application: Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring Orthopedics
3) By End User: Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers

Subsegments:
1) By Assays Kits: cfDNA Assays, ctDNA Assays, Exosome-based Assays, RNA-based Assays, Protein-based Assays
2) By Instruments: PCR Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, Mass Spectrometry Instruments
3) By Services: Testing Services, Data Analysis Services, Laboratory Services, Custom Assay Development Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2815&type=smp

Which Companies Are Leading the Charge in Liquid Biopsy Market Innovation?
Major companies operating in the liquid biopsy market include QIAGEN NV, Roche Diagnostics Ltd., Bio-Rad Laboratories Inc., Myriad Genetics Inc., Guardant Health Inc., Thermo Fisher Scientific Inc., Menarini Silicon Biosystems, Biocept Inc., Janssen Diagnostics LLC, Trovagene Inc., Fraunhofer-Gesellschaft, MDX Health SA, Agilent Technologies Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Quantum Biosystems Inc., Menarini Silicon Biosystems Inc., Pathway Genomics Corporation, Sysmex Corporation, Janssen Global Services LLC, Natera Inc., ANGLE Plc, Bio Techne Corp, Biodesix Inc., CellMax Inc., CIRCULOGENE, Exact Sciences Corporation, Epic Sciences Inc., Exosome Diagnostics Inc., GRAIL Inc., Guardant Health AMEA, Inivata Ltd., NIPD Genetics, Oncocyte Corporation, Personal Genome Diagnostics Inc., RainDance Technologies Inc., Thrive Earlier Detection Corp.

Which Regions Are Leading the Global Liquid Biopsy Market in Revenue?
North America was the largest region in the liquid biopsy market in 2023. Western Europe was the second largest region in the liquid biopsy market. The regions covered in the liquid biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2815

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.